Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers

摘要

Cancer treatment with a combination of an Epidermal Growth Factor Receptor tyrosine kinase inhibitor and an Interleukin-6 inhibitor.